GlassScriptPhysician profile
Matthew Alan King
NPI 1093209918
$5,092.64
in general payments reported to CMS, 2019-2025
15 companies · $44.08 in 2025
The $44.08 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,298 · 2022: $1,823 · 2023: $450 · 2024: $478 · 2025: $44.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $971.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $971.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,907.92 | 2021-2024 | 7 X 23mm Citrelock Implant, Bioskin, Citrefix |
| Alpha Orthopedic Systems | $1,299.73 | 2022-2024 | |
| Southtech Orthopedics | $1,200.00 | 2021 | |
| Integra Lifesciences Corporation | $153.35 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Forma Medical | $149.46 | 2024 | Optimalakin |
| Exactech, INC. | $92.05 | 2023 | |
| Smith+Nephew, INC. | $62.06 | 2022 | |
| Nevro Corp. | $53.70 | 2023-2024 | Senza |
| Stability Biologics, LLC | $36.32 | 2021 | |
| Organogenesis INC. | $32.95 | 2023-2024 | Puraply |
| Treace Medical Concepts, INC. | $29.68 | 2022 | |
| Depuy Synthes Sales INC. | $26.89 | 2025 | Motoband |
| Paratek Pharmaceuticals, INC. | $18.71 | 2022 | |
| Arteriocyte Medical Systems, INC. | $17.19 | 2025 | Magellan |
| Medartis INC. | $12.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.